Program Overview

Are you confident caring for patients with Alzheimer’s disease (AD)? Can you determine individualized treatment approaches for patients with this challenging disease? In this 45-minute CliniClip activity, neurology expert Richard S. Isaacson, MD, reviews strategies for care collaboration, approaches for patient-specific treatment decisions, and how to effectively communicate with patients and caregivers impacted by AD. 

Target Audience
Physicians, nurse practitioners, and physician assistants in neurology, primary care, and geriatrics.

Learning Objectives
Upon completion of this activity, learners should be better able to:

• DESCRIBE strategies for care collaboration among disciplines and across specialties to optimize care for patients with Alzheimer’s disease (AD)
• DETERMINE patient-specific pharmacologic treatment approaches for patients with AD
• IMPLEMENT approaches for effective communication with patients and caregivers surrounding AD diagnosis and management

Faculty

Richard S. Isaacson, MD
Institute for Neurodegenerative Diseases
Miami, Florida
Director of Brain Health, Atria Institute
New York City, NY

Providership & Support

This educational activity is jointly provided by the American Academy of CME and Spire Learning.

This activity is supported by an independent educational grant from Corium Inc.

Conflicts of Interest Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.

Disclosure of relevant financial relationships are as follows:

Faculty
Richard S. Isaacson, MD
Institute for Neurodegenerative Diseases
Miami, Florida
Director of Brain Health, Atria Institute
New York City, NY
 
Disclosure
Advisory Board/Consultant: Acadia Pharmaceuticals, Biogen, Inc, Genentech, a member of the Roche Group, Lilly

Educational Planning Committee
American Academy of CME
John JD Juchniewicz, MCIS, CHCP, FACEHP and Paul J. Miniter, MS American Academy of CME: No relevant financial relationships with ineligible companies.

Reviewer
Sarah Dehoney, PharmD, BCPS: No relevant financial relationships with ineligible companies.

Spire Learning
Mairead Early and Ashton Webb, PharmD, BCACP: No relevant financial relationships with ineligible companies.

Disclosure of Unlabeled or Investigational Use
This educational activity will contain discussion of published and/or investigational uses of agents for the management of Alzheimer’s disease that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer
The opinions expressed in this educational activity are those of the faculty and do not represent those of the Academy or Spire Learning. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.

Privacy Policy
For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm

Spire Learning, LLC is committed to protecting the privacy of personal information from our participants and educational collaborators. Spire maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of personal information.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing an activity. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of each activity. All evaluative information submitted is collected and retained, and used by Spire Learning, LLC to continuously improve the learning experience.
 
Spire Learning, LLC will not transfer, sell, or share personal information with outside parties or otherwise disclose personal information unless required to in a legal process. Spire will retain your personal data only for the period necessary to accomplish the stated purposes and to comply with applicable laws.

Copyright Information
Copyright © 2023 by Spire Learning, LLC and American Academy of CME. All rights reserved including translation into other languages. Through this notice, the Academy and Spire Learning, LLC grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above